Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 247-253

  Parikh, Ravi H ^a   Seliger, Stephen L ^a   deFilippi, Christopher R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myocardial infarction; Cardiovascular mortality; Chronic kidney disease; High sensitivity; Prognosis; Review; Troponin

Indexed keywords

HIGH SENSITIVITY CARDIAC TROPONIN; TROPONIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GRAFT RECIPIENT; HUMAN; KIDNEY CLEARANCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; BLOOD; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

BIOMARKERS; CROSS-SECTIONAL STUDIES; HUMANS; LONGITUDINAL STUDIES; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TROPONIN I; TROPONIN T;

EID: 84925467474     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.01.004     Document Type: Review

References (89)

1. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108(17):2154-2169.
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351(13):1296-1305.
3. Hostetter T.H. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004, 351(13):1344-1346.
4. McCullough P.A., Li S., Jurkovitz C.T., Stevens L., Collins A.J., Chen S.C., et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 2008, 156(2):277-283.
5. Khan N.A., Hemmelgarn B.R., Tonelli M., Thompson C.R., Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005, 112(20):3088-3096.
6. Wang A.Y., Lam C.W., Chan I.H., Wang M., Lui S.F., Sanderson J.E. Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension 2010, 56(2):210-216.
7. Lowbeer C., Ottosson-Seeberger A., Gustafsson S.A., Norrman R., Hulting J., Gutierrez A. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol Dial Transplant 1999, 14(8):1948-1955.
8. Goicoechea M., Garca de Vinuesa S., Gomez-Campdera F., Gutierrez M.J., Blanco P., Amann R., et al. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk. Am J Kidney Dis 2004, 43(5):846-853.
9. Abbas N.A., John R.I., Webb M.C., Kempson M.E., Potter A.N., Price C.P., et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 2005, 51(11):2059-2066.
10. Aviles R.J., Askari A.T., Lindahl B., Wallentin L., Jia G., Ohman E.M., et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002, 346(26):2047-2052.
11. deFilippi C., Seliger S.L., Kelley W., Duh S.H., Hise M., Christenson R.H., et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem 2012, 58(9):1342-1351.
12. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361(9):868-877.
13. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361(9):858-867.
14. Januzzi J.L., Bamberg F., Lee H., Truong Q.A., Nichols J.H., Karakas M., et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010, 121(10):1227-1234.
15. Kavsak P.A., Wang X., Ko D.T., MacRae A.R., Jaffe A.S. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009, 55(10):1809-1815.
16. Freund Y., Chenevier-Gobeaux C., Bonnet P., Claessens Y.E., Allo J.C., Doumenc B., et al. High-sensitivity versus conventional troponin in the emergency department for the diagnosis of acute myocardial infarction. Crit Care 2011, 15(3):R147.
17. Zuily S., Chenevier-Gobeaux C., Claessens Y.E., Wahbi K., Weber S., Meune C. High diagnostic performance of a high-sensitivity cardiac troponin T assay in patients with suspected acute coronary syndrome. Int J Cardiol 2011, 146(1):115-116.
18. Giannitsis E., Becker M., Kurz K., Hess G., Zdunek D., Katus H. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010, 56(4):642-650.
19. Chenevier-Gobeaux C., Meune C., Blanc M.C., Cynober L., Jaffray P., Lefevre G. Analytical evaluation of a high-sensitivity troponin T assay and its clinical assessment in acute coronary syndrome. Ann Clin Biochem 2011, 48(Pt 5):452-458.
20. deFilippi C., Wasserman S., Rosanio S., Tiblier E., Sperger H., Tocchi M., et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003, 290(3):353-359.
21. Hayashi T., Obi Y., Kimura T., Iio K., Sumitsuji S., Takeda Y., et al. Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy. Nephrol Dial Transplant 2008, 23(9):2936-2942.
22. Charytan D., Kuntz R.E., Mauri L., DeFilippi C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007, 49(3):409-416.
23. Chonchol M., Whittle J., Desbien A., Orner M.B., Petersen L.A., Kressin N.R. Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol 2008, 28(2):354-360.
24. Ohtake T., Kobayashi S., Moriya H., Negishi K., Okamoto K., Maesato K., et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005, 16(4):1141-1148.
25. Kawai H., Sarai M., Motoyama S., Harigaya H., Ito H., Sanda Y., et al. Coronary plaque characteristics in patients with mild chronic kidney disease. Analysis by 320-row area detector computed tomography. Circ J 2012, 76(6):1436-1441.
26. Melloni C., Alexander K.P., Milford-Beland S., Newby L.K., Szczech L.A., Pollack C.V., et al. Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease. Clin Cardiol 2008, 31(3):125-129.
27. Acharji S., Baber U., Mehran R., Fahy M., Kirtane A.J., Lansky A.J., et al. Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial. Circ Cardiovasc Interv 2012, 5(2):157-165.
28. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60(16):1581-1598.
29. Chenevier-Gobeaux C., Meune C., Freund Y., Wahbi K., Claessens Y.E., Doumenc B., et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. Am J Cardiol 2013, 111(12):1701-1707.
30. Pfortmueller C.A., Funk G.C., Marti G., Leichtle A.B., Fiedler G.M., Schwarz C., et al. Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. Am J Cardiol 2013, 112(12):1968-1972.
31. Reichlin T., Irfan A., Twerenbold R., Reiter M., Hochholzer W., Burkhalter H., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011, 124(2):136-145.
32. Haaf P., Reichlin T., Twerenbold R., Hoeller R., Rubini Gimenez M., Zellweger C., et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J 2014, 35(6):365-375.
33. Stacy S.R., Suarez-Cuervo C., Berger Z., Wilson L.M., Yeh H.C., Bass E.B., et al. Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med 2014, 161(7):502-512.
34. Lamb E.J., Kenny C., Abbas N.A., John R.I., Webb M.C., Price C.P., et al. Cardiac troponin I concentration is commonly increased in nondialysis patients with CKD: experience with a sensitive assay. Am J Kidney Dis 2007, 49(4):507-516.
35. Kitagawa M., Sugiyama H., Morinaga H., Inoue T., Takiue K., Kikumoto Y., et al. Serum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease. Nephron Extra 2011, 1(1):166-177.
36. Mishra R.K., Li Y., DeFilippi C., Fischer M.J., Yang W., Keane M., et al. Association of cardiac troponin T with left ventricular structure and function in CKD. Am J Kidney Dis 2013, 61(5):701-709.
37. Dubin R.F., Li Y., He J., Jaar B.G., Kallem R., Lash J.P., et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol 2013, 14:229.
38. Bansal N., Hyre Anderson A., Yang W., Christenson R.H., deFilippi C.R., Deo R., et al. High-sensitivity troponin T and N-terminal Pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the chronic renal insufficiency cohort (CRIC) study. J Am Soc Nephrol 2014, pii: ASN.2014010108. [Epub ahead of print].
39. Scheven L., de Jong P.E., Hillege H.L., Lambers Heerspink H.J., van Pelt L.J., Kootstra J.E., et al. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. Eur Heart J 2012, 33(18):2272-2281.
40. Michos E.D., Wilson L.M., Yeh H.C., Berger Z., Suarez-Cuervo C., Stacy S.R., et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review. Ann Intern Med 2014, 161(7):491-501.
41. Jacobs L.H., van de Kerkhof J., Mingels A.M., Kleijnen V.W., van der Sande F.M., Wodzig W.K., et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009, 46(Pt 4):283-290.
42. McGill D., Talaulikar G., Potter J.M., Koerbin G., Hickman P.E. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010, 411(13-14):936-939.
43. Wolley M., Stewart R., Curry E., Davidson J., White H., Pilmore H. Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patients. Clin Kidney J 2012, 6(4):402-409.
44. Hassan H.C., Howlin K., Jefferys A., Spicer S.T., Aravindan A.N., Suryanarayanan G., et al. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clin Chem 2014, 60(2):389-398.
45. Gaiki M.R., DeVita M.V., Michelis M.F., Panagopoulos G., Rosenstock J.L. Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay. Int Urol Nephrol 2012, 44(6):1841-1845.
46. Assa S., Gansevoort R.T., Westerhuis R., Kobold A.C., Voors A.A., de Jong P.E., et al. Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients. Clin Res Cardiol 2013, 102(6):439-445.
47. Dikow R., Hardt S.E. The uremic myocardium and ischemic tolerance: a world of difference. Circulation 2012, 125(10):1215-1216.
48. Burton J.O., Jefferies H.J., Selby N.M., McIntyre C.W. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009, 4(5):914-920.
49. Aoki J., Ikari Y., Nakajima H., Mori M., Sugimoto T., Hatori M., et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 2005, 67(1):333-340.
50. Diris J.H., Hackeng C.M., Kooman J.P., Pinto Y.M., Hermens W.T., van Dieijen-Visser M.P. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004, 109(1):23-25.
51. Bates K.J., Hall E.M., Fahie-Wilson M.N., Kindler H., Bailey C., Lythall D., et al. Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction. Clin Chem 2010, 56(6):952-958.
52. Fahie-Wilson M.N., Carmichael D.J., Delaney M.P., Stevens P.E., Hall E.M., Lamb E.J. Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin Chem 2006, 52(3):414-420.
53. Ziebig R., Lun A., Hocher B., Priem F., Altermann C., Asmus G., et al. Renal elimination of troponin T and troponin I. Clin Chem 2003, 49(7):1191-1193.
54. Keddis M.T., El-Zoghby Z.M., El Ters M., Rodrigo E., Pellikka P.A., Jaffe A.S., et al. Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival. Am J Transplant 2013, 13(2):406-414.
55. Wu A.H., Feng Y.J., Roper L., Herbert K., Schweizer R. Cardiac troponins T and I before and after renal transplantation. Clin Chem 1997, 43(2):411-412.
56. McNeil A.R. Implications of a rapid decrease in serum Troponin T levels after renal transplantation. Aust N Z J Med 2000, 30(5):638-639.
57. Bozbas H., Korkmaz M.E., Atar I., Eroglu S., Ozin B., Yildirir A., et al. Serum levels of cardiac enzymes before and after renal transplantation. Clin Cardiol 2004, 27(10):559-562.
58. Fredericks S., Chang R., Gregson H., Bewick M., Collinson P.O., Gaze D., et al. Circulating cardiac troponin-T in patients before and after renal transplantation. Clin Chim Acta 2001, 310(2):199-203.
59. Ellis K., Dreisbach A.W., Lertora J.L. Plasma elimination of cardiac troponin I in end-stage renal disease. South Med J 2001, 94(10):993-996.
60. Mockel M., Schindler R., Knorr L., Muller C., Heller G., Stork T.V., et al. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant 1999, 14(6):1489-1495.
61. Peetz D., Schutt S., Sucke B., Faldum A., Wandel E., Hafner G., et al. Prognostic value of troponin T, troponin I, and CK-MB mass in patients with chronic renal failure. Med Klin (Munich) 2003, 98(4):188-192.
62. Farkouh M.E., Robbins M.J., Zafar M.U., Shimbo D., Davidson K.W., Puttappa R., et al. Association between troponin I levels and mortality in stable hemodialysis patients. Am J Med 2003, 114(3):224-226.
63. Wayand D., Baum H., Schatzle G., Scharf J., Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem 2000, 46(9):1345-1350.
64. Lippi G., Tessitore N., Montagnana M., Salvagno G.L., Lupo A., Guidi G.C. Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T. Arch Pathol Lab Med 2008, 132(1):72-76.
65. Conway B., McLaughlin M., Sharpe P., Harty J. Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol Dial Transplant 2005, 20(12):2759-2764.
66. Sommerer C., Beimler J., Schwenger V., Heckele N., Katus H.A., Giannitsis E., et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 2007, 37(5):350-356.
67. Frankel W.L., Herold D.A., Ziegler T.W., Fitzgerald R.L. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 1996, 106(1):118-123.
68. Collinson P.O., Hadcocks L., Foo Y., Rosalki S.B., Stubbs P.J., Morgan S.H., et al. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem 1998, 35(Pt 3):380-386.
69. Ooi D.S., House A.A. Cardiac troponin T in hemodialyzed patients. Clin Chem 1998, 44(7):1410-1416.
70. Tun A., Khan I.A., Win M.T., Hussain A., Hla T.A., Wattanasuwan N., et al. Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology 1998, 90(4):280-285.
71. Deleaval P., Descombes E., Magnin J.L., Martin P.Y., Fellay G. Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays. Nephrol Ther 2006, 2(2):75-81.
72. Mongeon F.-P., Dorais M., Lorier J.L., Froment D., Letendre É., Rinfret S. Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin T: a prospective survey over one year. Open Cardiovasc Med J 2009, 3:69-77.
73. Tarakcioglu M., Erbagci A., Cekmen M., Usalan C., Cicek H., Ozaslan J., et al. Acute effect of haemodialysis on serum markers of myocardial damage. Int J Clin Pract 2002, 56(5):328-332.
74. Kumar N., Michelis M.F., DeVita M.V., Panagopoulos G., Rosenstock J.L. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant 2011, 26(2):665-670.
75. Dasselaar J.J., Slart R.H.J.A., Knip M., Pruim J., Tio R.A., McIntyre C.W., et al. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 2009, 24(2):604-610.
76. McIntyre C.W., Burton J.O., Selby N.M., Leccisotti L., Korsheed S., Baker C.S.R., et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008, 3(1):19-26.
77. Assa S., Hummel Y.M., Voors A.A., Kuipers J., Westerhuis R., de Jong P.E., et al. Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance. Clin J Am Soc Nephrol 2012, 7(10):1615-1623.
78. Kajimoto H., Kai H., Aoki H., Yasuoka S., Anegawa T., Aoki Y., et al. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kidney Int 2012, 81(8):762-768.
79. Del Vecchio L., Locatelli F., Carini M. What we know about oxidative stress in patients with chronic kidney disease on dialysis-clinical effects, potential treatment, and prevention. Semin Dial 2011, 24(1):56-64.
80. Amann K., Breitbach M., Ritz E., Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998, 9(6):1018-1022.
81. Lowbeer C., Stenvinkel P., Pecoits-Filho R., Heimburger O., Lindholm B., Gustafsson S.A., et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 2003, 253(2):153-160.
82. Sezer S., Karakan S., Ozdemir N. Increased cardiac troponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients. Ren Fail 2012, 34(4):454-459.
83. London G.M. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002, 17(Suppl. 1):29-36.
84. Ooi D.S., Veinot J.P., Wells G.A., House A.A. Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. Clin Biochem 1999, 32(8):647-652.
85. Sharma R., Gaze D.C., Pellerin D., Mehta R.L., Gregson H., Streather C.P., et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006, 92(6):804-809.
86. deFilippi C.R., Thorn E.M., Aggarwal M., Joy A., Christenson R.H., Duh S.H., et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 2007, 100(5):885-889.
87. Lentine K.L., Costa S.P., Weir M.R., Robb J.F., Fleisher L.A., Kasiske B.L., et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the american heart association and the american college of cardiology foundation. Circulation 2012, 126(5):617-663.
88. Connolly G.M., Cunningham R., McNamee P.T., Young I.S., Maxwell A.P. Troponin T is an independent predictor of mortality in renal transplant recipients. Nephrol Dial Transplant 2008, 23(3):1019-1025.
89. Arroyo D., Quiroga B., Panizo N., Rodriguez-Ferrero M., Macias N., Reque J., et al. High-sensitivity troponin T levels in kidney transplant recipients. Transplant Proc 2012, 44(9):2545-2547.